TrialThe oncologist2026

Anlotinib in combination with trifluridine-tipiracil in patients with refractory metastatic colorectal cancers: a phase II, single arm study.

Qing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.